Stock AURORA CANNABIS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Aurora Cannabis Inc Share Price Toronto S.E.

Equities

CA7561027037

Pharmaceuticals

Financials

Sales 2024 * 272M 199M 16.59B Sales 2025 * 320M 234M 19.49B Capitalization 501M 366M 30.57B
Net income 2024 * -61M -44.59M -3.72B Net income 2025 * -7M -5.12M -427M EV / Sales 2024 * 1.84 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 1.57 x
P/E ratio 2024 *
-5.87 x
P/E ratio 2025 *
-56.6 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 100%
More Fundamentals * Assessed data

Chart Aurora Cannabis Inc

Dynamic Chart

Latest news about Aurora Cannabis Inc

Cannabis Stocks Rise Pre-Bell After Florida Supreme Court Allows Ballot Initiative to Legalize Marijuana MT
Pot producers climb as recreational cannabis to go on Florida ballot RE
Cannabis Stocks: Wedbush Notes Florida Supreme Court Approved Proposed Amendment For Adult Use Cannabis to be Placed on the 2024 General Election Ballot MT
High Tide, Aurora Cannabis Mixed In US Premarket Trade As Both Note Start of German Cannabis Legalization MT
Aurora Cannabis Brief: Notes Germany's "Landmark" Legalization Achievement; Says Expected De-scheduling of Cannabis to Fuel Expansion of Medical Cannabis Market in Germany MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Markets Take Breather After Last Week's Rally MT
US Equity Markets Close Mixed Friday as Dow Drops After Approaching 40,000 MT
Sector Update: Consumer Stocks Slipping Late Afternoon MT
Sector Update: Consumer MT
Top Midday Gainers MT
Aurora, Canopy Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law MT
Aurora Cannabis, Canopy Growth Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law MT
Aurora Cannabis, Canopy Growth Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law MT
Cannabis Review Panel Recommends Changes to Excise Tax, Health Canada Regulations MT
Aurora Cannabis Shares Rise After Receipt of Australian Regulator's Certification MT
More news

Latest transcript on Aurora Cannabis Inc

Logo Aurora Cannabis Inc
Aurora Cannabis Inc., Q3 2024 Earnings Call, Feb 08, 2024
More transcripts

Analyst Recommendations on Aurora Cannabis Inc

Aurora, Canopy Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law MT
Canaccord Genuity Upgrades Aurora Cannabis to Buy From Hold MT
CIBC Adjusts Aurora Cannabis Price Target to CA$1 From CA$1.75, Maintains Neutral Rating MT
Aurora Cannabis Price Target Lowered to $1 at CIBC MT
Aurora Cannabis Brief: For Q1 2024, Expects Adjusted Gross Margins to be consistent with fiscal Q3 2023 and expects to maintain stated objective of a quarterly SG&A expense run rate below $30 million MT
More recommendations

Press releases Aurora Cannabis Inc

Sector Spotlight: Top 4 Stocks To Watch In The Rising Cannabis Market AQ
Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia AQ
Aurora Cannabis buys Australian medical pot firm as losses continue AQ
Aurora Cannabis to consolidate shares on a one-for-10 basis AQ
Aurora Cannabis revenues rise in Q2, led by strength in medical cannabis sales AQ
More press releases

News in other languages on Aurora Cannabis Inc

Cannabis: Die Branche schwebt wieder auf Wolke sieben
Cannabis: El sector vuelve a dispararse
Cannabis : le secteur plane à nouveau
UN-Drogenkontrollrat warnt Deutschland vor Cannabis-Legalisierung
Aktien von Cannabis-Anbieter Cantourage heben bei Debüt ab
More news

Managers and Directors - Aurora Cannabis Inc

Managers TitleAgeSince
Miguel Martin CEO
 Chief Executive Officer 52 06/20/06
Simona King DFI
 Director of Finance/CFO 52 21/02
Dave Aird CTO
 Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Ronald Funk CHM
 Chairman 67 25/18/25
Michael Singer BRD
 Director/Board Member 60 20/16/20
Adam Szweras BRD
 Director/Board Member 52 10/15/10
More insiders

Company Profile

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.
Sector
Pharmaceuticals
Calendar
09/05/2024 - Q4 2024 Earnings Release (Projected)
More about the company

Sector Alternative Medicine

1st Jan change Capi.
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+35.04% 5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.13% 4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.75% 3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+2.14% 3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-6.82% 2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+47.87% 1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-7.89% 1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+0.09% 1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.97% 1.53B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. ACB Stock
  4. Stock